Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP study

Treatment options for Hepatitis C infection have greatly improved with direct-acting antiviral (DAA) combinations achieving high cure rates. Nevertheless, the cost of this treatment is still high and access to treatment in many countries has been preferentially reserved for patients with more severe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Epidemiol Infect
Autores principales: Semenova, T., Nemoz, B., Thibault, V., Lagathu, G., Duverlie, G., Brochot, E., Trimoulet, P., Payan, C., Vallet, S., Henquell, C., Chevaliez, S., Bouvier-Alias, M., Maylin, S., Roque-Afonso, A-M., Izquierdo, L., Lunel-Fabiani, F., Marcellin, P., Morand, P., Leroy, V., Larrat, S.
Formato: Artigo
Lenguaje:Inglês
Publicado: Cambridge University Press 2019
Materias:
Original Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6625182/
https://ncbi.nlm.nih.gov/pubmed/31364570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S0950268819001225
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares